Adaptimmune Therapeutics Statistics

Total Valuation

ADAP has a market cap or net worth of $212.98 million. The enterprise value is $84.15 million.

Market Cap	212.98M
Enterprise Value	84.15M

Important Dates

The next estimated earnings date is Friday, May 10, 2024, before market open.

Earnings Date	May 10, 2024
Ex-Dividend Date	n/a

Share Statistics

ADAP has 237.06 million shares outstanding.

Shares Outstanding	237.06M
Owned by Insiders (%)	0.20%
Owned by Institutions (%)	67.52%
Float	n/a

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	3.47
Forward PS	3.07
PB Ratio	5.29
P/FCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.40
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.85, with a Debt / Equity ratio of 0.64.

Current Ratio	2.85
Quick Ratio	2.07
Debt / Equity	0.64
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -134.70% and return on invested capital (ROIC) is -215.82%.

Return on Equity (ROE)	-134.70%
Return on Assets (ROA)	-37.60%
Return on Capital (ROIC)	-215.82%
Revenue Per Employee	$134,256
Profits Per Employee	-$253,610
Employee Count	449
Asset Turnover	0.20
Inventory Turnover	n/a

Taxes

In the past 12 months, ADAP has paid $1.34 million in taxes.

Income Tax	1.34M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -33.45% in the last 52 weeks. The beta is 2.38, so ADAP's price volatility has been higher than the market average.

Beta (1Y)	2.38
52-Week Price Change	-33.45%
50-Day Moving Average	1.39
200-Day Moving Average	0.89
Relative Strength Index (RSI)	25.49
Average Volume (30 Days)	1,967,837

Short Selling Information

Short Interest	3.20M
Short Previous Month	3.11M
Short % of Shares Out	2.97%
Short % of Float	n/a
Short Ratio (days to cover)	1.64

Income Statement

In the last 12 months, ADAP had revenue of $60.28 million and -$113.87 million in losses. Loss per share was -$0.54.

Revenue	60.28M
Gross Profit	60.28M
Operating Income	-139.74M
Pretax Income	-112.54M
Net Income	-113.87M
EBITDA	-102.70M
EBIT	-112.54M
Loss Per Share	-$0.54

Full Income Statement

Balance Sheet

The company has $149.96 million in cash and $25.24 million in debt, giving a net cash position of $124.73 million or $0.53 per share.

Cash & Cash Equivalents	149.96M
Total Debt	25.24M
Net Cash	124.73M
Net Cash Per Share	$0.53
Equity / Book Value	39.51M
Book Value Per Share	0.17
Working Capital	134.76M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$140.88 million and capital expenditures -$4.68 million, giving a free cash flow of -$145.56 million.

Operating Cash Flow	-140.88M
Capital Expenditures	-4.68M
Free Cash Flow	-145.56M
FCF Per Share	-$0.72

Full Cash Flow Statement

Margins

Gross margin is 100.00%, with operating and profit margins of -231.82% and -188.90%.

Gross Margin	100.00%
Operating Margin	-231.82%
Pretax Margin	-186.68%
Profit Margin	-188.90%
EBITDA Margin	-170.36%
EBIT Margin	-186.68%
FCF Margin	-241.47%

Dividends & Yields

ADAP does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-24.73%
Shareholder Yield	-24.73%
Earnings Yield	-54.52%
FCF Yield	-69.69%

Analyst Forecast

The average price target for ADAP is $5.50, which is 512.20% higher than the current price. The consensus rating is "Buy".

Price Target	$5.50
Price Target Difference	512.20%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	16.16%
EPS Growth Forecast (5Y)	n/a

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

ADAP has an Altman Z-Score of -5.08 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-5.08
Piotroski F-Score	2